eli lilly glp-1 receptor agonist products launches weight-loss drug Mounjaro in India, beats Novo Nordisk to major market As GLP-1 Use Expands, Long-Term
Description
This isn't unique to GLP-1 medications

Glucosedependent insulinotropic peptide is an integrative hormone with osteotropic effects

Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of alzheimers disease

Two consecutive missed doses, however, substantially erode your baseline, and the plotter shows just how much ground you lose
Transcriptomic analyses of MSC-Ex-4 under glucose stimulation (25 mM) revealed 1323 differentially expressed genes, with enrichment patterns indicating regulatory effects on pathways related to proliferation, apoptosis, and cell cycle regulation

Overall, GLP-1 RAs appear to be more efficacious than DPP4 inhibitors in people with type 2 diabetes in terms of improving glycaemic control and reducing body weight (Gilbert and Pratley, 2020)
